Case Series: Management of Elevated Lipoprotein(a) by Double-Filtration Plasmapheresis in Hemodialysis Patients With Chronic Kidney Disease
Ther Apher Dial. 2026 Aug 21. doi: 10.1002/1744-9987.70213. Online ahead of print.ABSTRACTBACKGROUND: Elevated lipoprotein(a) (Lp(a)) is a recognized independent cardiovascular risk factor, particularly in patients with chronic kidney disease (CKD) undergoing hemodialysis, for whom pharmacological t

